Cerebral microbleeds: a guide to detection and interpretation

Steven M Greenberg1, Meike W Vernooij, Charlotte Cordonnier

  • 1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. sgreenberg@partners.org

The Lancet. Neurology
|January 24, 2009
PubMed

Insights

Cerebral microbleeds (CMBs) are common in aging and dementia. Newer MRI techniques improve detection, but results depend on imaging methods, influencing interpretation of their role in small-vessel brain disease.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Cerebral microbleeds (CMBs) are recognized neuroimaging findings in cerebrovascular disease, dementia, and normal aging.
  • Recent advancements in MRI techniques have significantly improved CMB detection, particularly in elderly populations.

Purpose of the Study:

  • To review recent developments in MRI methods for detecting cerebral microbleeds (CMBs).
  • To discuss how MRI technique influences the interpretation of CMB detection and prevalence.
  • To propose a guide for CMB identification and future research directions.

Main Methods:

  • Review of recent literature on MRI techniques for cerebral microbleed (CMB) detection.
  • Analysis of factors influencing CMB detection, including MRI pulse sequence, parameters, resolution, field strength, and post-processing.
  • Application of sensitive MRI techniques to population-based samples of elderly individuals.

Main Results:

  • The number of detected cerebral microbleeds (CMBs) is highly dependent on specific MRI characteristics.
  • Sensitive MRI techniques reveal a high prevalence of CMBs in community-dwelling elderly individuals.
  • Interpretation of CMBs requires careful consideration of the MRI techniques employed.

Conclusions:

  • MRI technique is crucial for accurate cerebral microbleed (CMB) detection and interpretation.
  • CMBs are highly prevalent in the elderly, underscoring their significance in small-vessel brain disease.
  • Further research is needed to elucidate the role of CMBs as markers and contributors to brain disease.